Position in OPTH
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$523,221
New position
Shares Held
102,794
first reported quarter
Ownership
1.80%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2
of 10 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026AdvisorShares Investments LLC holds $261,923,894 across 17 Drug Manufacturers - Specialty & Generic names. OPTH ranks #11 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CURLF |
Curaleaf Holdings, Inc.
|
12,420,961 | $134,270,588 | |
| 2 | TRLV |
Trulieve Cannabis Corp.
|
10,641,152 | $104,602,524 | |
| 3 | GLAS |
Glass House Brands Inc.
|
850,000 | $11,050,000 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
11,553 | $1,947,142 | |
| 5 | ALKS |
Alkermes plc.
|
36,438 | $1,909,351 | |
| 6 | CRON |
Cronos Group Inc.
|
482,394 | $1,341,055 | |
| 7 | SUPN |
Supernus Pharmaceuticals, Inc.
|
27,618 | $1,284,513 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
32,883 | $1,114,076 |
All Filings in OPTH
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $523,221 | 102,794 | Shares | Sole | 2026-08-11 | |
| No filing history on record for this holder in this stock. | ||||||